Abstract:Research ethics review committees (ERCs) worldwide faced daunting challenges during the COVID-19 pandemic. There was a need to balance rapid turnaround with rigorous evaluation of high-risk research protocols in the context of considerable uncertainty. This study explored the experiences and performance of ERCs during the pandemic. We conducted an anonymous, cross-sectional, global online survey of chairs (or their delegates) of ERCs who were involved in the review of COVID-19-related research protocols after March 2020. The survey ran from October 2022 to February 2023 and consisted of 50 items, with opportunities for descriptive responses to open-ended questions. Two hundred and three participants [130 from high-income countries (HICs) and 73 from low- and middle-income countries (LMICs)] completed our survey. Respondents came from diverse entities and organizations from 48 countries (19 HICs and 29 LMICs) in all World Health Organization regions. Responses show little of the increased global funding for COVID-19 research was allotted to the operation of ERCs. Few ERCs had pre-existing internal policies to address operation during public health emergencies, but almost half used existing guidelines. Most ERCs modified existing procedures or designed and implemented new ones but had not evaluated the success of these changes. Participants overwhelmingly endorsed permanently implementing several of them. Few ERCs added new members but non-member experts were consulted; quorum was generally achieved. Collaboration among ERCs was infrequent, but reviews conducted by external ERCs were recognized and validated. Review volume increased during the pandemic, with COVID-19-related studies being prioritized. Most protocol reviews were reported as taking less than three weeks. One-third of respondents reported external pressure on their ERCs from different stakeholders to approve or reject specific COVID-19-related protocols. ERC members faced significant challenges to keep their committees functioning during the pandemic. Our findings can inform ERC approaches towards future public health emergencies. To our knowledge, this is the first international, COVID-19-related study of its kind.

Ethical Challenges in Clinical Research During the COVID-19 Pandemic

The ethics of clinical research in the era of COVID-19

Ethical Frameworks in Clinical Research Processes During COVID-19: a Scoping Review

Ethical Challenges Arising in the COVID-19 Pandemic: An Overview from the Association of Bioethics Program Directors (ABPD) Task Force

Fundamental Shifts in Research, Ethics and Peer Review in the Era of the COVID-19 Pandemic

Ethical rationale for better coordination of clinical research on COVID-19

Optimizing Clinical Research Procedures in Public Health Emergencies

Ethical challenges during critical phases of the COVID-19 pandemic: An interpretive synthesis

COVID-19 ethics: unique aspects and a review as of early 2024

A narrative review of the challenges, ethical frameworks, and guidelines in the setting of COVID-19 healthcare and research

Bioethics in Medical Care Rationing During the Coronavirus Disease-19 Pandemic

Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial

Ethical Considerations for Qualitative Research Methods During the COVID-19 Pandemic and Other Emergency Situations: Navigating the Virtual Field

Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation

How the clinical research community responded to the COVID-19 pandemic: An analysis of the COVID-19 clinical studies in ClinicalTrials.gov

Research ethics review during the COVID-19 pandemic: An international study

Psychological, Behavioral, and Interpersonal Effects and Clinical Implications for Health Systems of the Coronavirus (COVID-19) Pandemic: A Call for Research

Ethical issues under the pressure of COVID-19 pandemic

Practising in a post-truth world: Pandemic ethics can inform patient autonomy and clinical communication

Ethical Considerations in Oncology and Palliative Care Research During COVID-19

The Ethical Obligation to Treat Infectious Patients: A Systematic Review of Reasons